Ligand-Based Pharmacophore Modeling and Virtual Screening of RAD9 Inhibitors
Human RAD9 is a key cell-cycle checkpoint protein that participates in DNA repair, activation of multiple cell cycle phase checkpoints, and apoptosis. Aberrant RAD9 expression has been linked to breast, lung, thyroid, skin, and prostate tumorigenesis. Overexpression of RAD9 interacts with BCL-2 prot...
Saved in:
Main Authors: | Nirmal K. Prasad, Vishnupriya Kanakaveti, Siddhartha Eadlapalli, Ramakrishna Vadde, Angamba Potshangbam Meetei, Vaibhav Vindal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2013/679459 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel inhibitors of the (VIBVN) NAT protein identified through pharmacophore modeling
by: Wei Wei, et al.
Published: (2025-01-01) -
Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01) -
dyphAI dynamic pharmacophore modeling with AI: a tool for efficient screening of new acetylcholinesterase inhibitors
by: Yasser Hayek-Orduz, et al.
Published: (2025-02-01) -
Multi-stage structure-based virtual screening approach combining 3D pharmacophore, docking and molecular dynamic simulation towards the identification of potential selective PARP-1 inhibitors
by: Mahmoud A. El Hassab, et al.
Published: (2025-02-01) -
Identification of Novel LCN2 Inhibitors Based on Construction of Pharmacophore Models and Screening of Marine Compound Libraries by Fragment Design
by: Ningying Zheng, et al.
Published: (2025-01-01)